A snapshot of the US hospital denial management market

New HIMSS Analytics research shows adoption of vendor-provided denial management solutions remains relatively low.

The finding comes from HIMSS Analytics' recently released 2016 RCM Denial Management Essentials Brief, a study of the U.S. hospital denial management market.

For the study, 64 hospital executives, clinical, financial and operational department heads and IT personnel offered insight on their current denial management solution usage as well as future plans for denial management solution adoption.

Here are four findings from the study.

1. Fewer than half — 44 percent — of study respondents indicated their organization utilizes a vendor-provided denial management solution. Thirty-one percent of respondents said they use a manual process and 18 percent said they use a solution built in-house.

2. Organizations with vendor-provided solutions depend heavily on their clearinghouse vendors for denial management solutions, the study found. Other respondents indicated a mix of best of breed and EHR/HIS solutions.

3. When asked, on a scale from 0-10, how likely they are to recommend their denial management solution to a friend or colleague, the average rating from respondents was 7.13.

4. Roughly 60 percent of respondents plan to purchase a vendor-provided denial management solution in the next seven to 12 months.


More articles on finance and revenue cycle management:

Puerto Rico debt measure bill heads to President Obama
Tri-City medical group refutes audit revealing billing errors
Change Healthcare adds to software platform, nThrive launches RCM products & more — 9 RCM keynotes


Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars